RxDoctor Payments Data

Jill Sagona

Optometrist · Naples, FLNPI 1023126091

Payments from drug & device makers

$6,919in general payments, 2019–2025

Across 81 payments — averaging $85.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Alcon$788
  • Optovue, Inc.$709
  • Coopervision Inc.$650
  • Bausch & Lomb Americas Inc.$536
  • Johnson & Johnson Vision Care, Inc.$369
  • plus $1K from 10 others

What the payments were for

  • Consulting fees$5007%
  • Food & beverage$6,36592%
  • Education$541%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,919 in reported general payments places this provider in the 90th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida

Medicare billing

Part B allowed, 2024
$62,033
Medicare patients
375
Services billed
951

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IyuzehLatanoprost/Pf12$3,273
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$125
Latanoprost23$105

Paid to pharmacies, not to this prescriber.

Other optometrist in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →